Nutraceuticals Digestive Pathologies Treatment
Nutraceuticals Digestive Pathologies Treatment refers to the development and application of functional foods, probiotics, prebiotics, enzymes, botanical compounds, and dietary supplements designed to prevent, manage, or alleviate gastrointestinal disorders. This category recognizes innovations improving digestive health, gut microbiome balance, nutrient absorption, inflammation control, and supportive care for chronic or acute digestive pathologies.

Europe's Nutraceutical Shift: Personalized Digestive Health Powered by Biomarkers
In Europe, the nutraceutical industry is transitioning from a generalized approach to a personalized, biomarker-driven model, particularly for managing digestive disorders. The market for nutraceuticals addressing digestive health is robust and expanding, as consumers increasingly seek preventative and targeted solutions. This is where the application of biomarkers—measurable indicators of a biological state—becomes critical.

How do you foresee ongoing changes in services for oncology shaping the landscape of challenges you face in satisfying your business requirements?
